Record · corpus.blog/posts/01a0875e-1bb1-7222-9d70-4625da51bcd4

Computational Simulation Of Four Non-Covalent KRAS G12D Inhibitors Suggests Verastem's VS-7375 May Achieve The Deepest Signaling Suppression

chaotropy.com · published 24 April 2026

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at chaotropy.com Wayback capture

0blogs citing

First cited: —
Most recent: —
Rank this month: not ranked
Links from this post: 34
Words captured: 5,901

Cited by

No blog we hold has cited this post yet.

Links from this post

Link

Host

https://www.cancer.org/cancer/types/pancreatic-cancer/about/key-statistics.html

cancer.org

https://www.nature.com/articles/s41467-021-26213-y

nature.com

https://www.nature.com/articles/nature12796

nature.com

https://ir.revmed.com/news-releases/news-release-details/daraxonrasib-demonstrates-unprecedented-overall-survival-benefit

ir.revmed.com

https://clinicaltrials.gov/study/NCT06625320

clinicaltrials.gov

https://chaotropy.substack.com/p/phase-3-readout-of-daraxonrasib-in

chaotropy.substack.com

https://ascopubs.org/doi/10.1200/JCO.2025.43.4_suppl.722

ascopubs.org

https://aacrjournals.org/cancerres/article/85/8_Supplement_1/2928/761140/Abstract-2928-Combination-surface-targeting

aacrjournals.org

https://ir.revmed.com/news-releases/news-release-details/revolution-medicines-announces-fda-breakthrough-therapy-1

ir.revmed.com

https://ir.revmed.com/news-releases/news-release-details/revolution-medicines-reports-fourth-quarter-and-full-year-2025

ir.revmed.com

https://clinicaltrials.gov/study/NCT07154875

clinicaltrials.gov

https://clinicaltrials.gov/study/NCT06599502

clinicaltrials.gov

https://aacrjournals.org/cancerres/article/86/5_Supplement_1/PR007/774578

aacrjournals.org

https://investor.verastem.com/news-releases/news-release-details/verastem-oncology-announces-updated-data-partner-genfleet-0/

investor.verastem.com

https://investor.verastem.com/news-releases/news-release-details/verastem-oncology-announces-late-breaking-abstract-partner

investor.verastem.com

https://clinicaltrials.gov/study/NCT06500676

clinicaltrials.gov

https://clinicaltrials.gov/study/NCT07020221

clinicaltrials.gov

https://investor.verastem.com/news-releases/news-release-details/verastem-oncology-announces-encouraging-preliminary-data-ongoing/

investor.verastem.com

https://aacrjournals.org/cancerdiscovery/article/16/4/740/775562/Discovery-of-BBO-11818-a-Potent-and-Selective

aacrjournals.org

https://aacrjournals.org/mct/article/24/10_Supplement/A063/766318

aacrjournals.org

https://clinicaltrials.gov/study/NCT06917079

clinicaltrials.gov

https://investors.bbotx.com/news-releases/news-release-details/bbot-announces-new-clinical-data-advancing-its-portfolio-three

investors.bbotx.com

https://www.sciencedirect.com/science/article/pii/S1535610824002265?via%3Dihub

sciencedirect.com

https://dailyreporter.esmo.org/esmo-congress-2025/emerging-targets/novel-kras-g12c-and-g12d-inhibitors-show-early-signs-of-activity-in-advanced-solid-tumours

dailyreporter.esmo.org

https://clinicaltrials.gov/study/NCT05533463

clinicaltrials.gov

https://www.oncologypipeline.com/apexonco/double-trouble-incyte-kras

oncologypipeline.com

https://www.sciencedirect.com/science/article/pii/S0923753425024044?via%3Dihub

sciencedirect.com

https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.3013

ascopubs.org

https://www.annalsofoncology.org/article/S0923-7534(25

annalsofoncology.org

https://aacrjournals.org/mcr/article/13/9/1325/89607/Biochemical-and-Structural-Analysis-of-Common

aacrjournals.org

https://www.life-science-alliance.org/content/7/5/e202302245

life-science-alliance.org

https://www.science.org/doi/10.1126/science.aap8210

science.org

https://aacrjournals.org/cancerres/article/86/5_Supplement_1/PR007/774578/Abstract-PR007-Anti-tumor-efficacy-of-the

aacrjournals.org

https://www.science.org/doi/10.1126/scisignal.adx5186

science.org